Signant Health is the evidence generation company. We are focused on leveraging software, deep therapeutic and scientific knowledge, and operational expertise to consistently capture, aggregate, and reveal quality evidence for clinical studies across traditional, virtual, and hybrid trial models. For more than 25 years, over 600 sponsors and CROs of all sizes – including all Top 20 pharma – have trusted Signant solutions for remote and site-based eCOA, EDC, eConsent, RTSM, supply chain management, and data quality analytics.
An EDC Option You Didn’t Know You Had!
Signant Health offers the most comprehensive eClinical suite in life sciences, now featuring a recently acquired EDC/DDC solution proven in more than 3,000 clinical trials over 25+ years. Sponsors and CROs are switching to eCaseLink EDC for its ease of use, efficiency, flexibility, and superior support. Plus, study teams can choose a full-service or self-service model to accommodate the needs of any trial or program.
CLINICAL TRIAL OPTIMIZATION
Signant’s comprehensive, end-to-end clinical trial optimization solutions are fully supported by more than fifty full-time clinicians, scientists, medical practitioners, and key opinion leaders experienced in all therapeutic areas. In addition to reliable, proven solutions and scientific expertise, sponsors and CROs leverage Signant’s global scale and trial delivery expertise. Our approach to trial optimization is to ensure the best practices and best solutions are in place to help your programs succeed. Explore these resources to learn more about how this approach ensures trials generate reliable, accurate, submission-ready data.
RESOURCES & PERSPECTIVES
Increasing The Usefulness Of PROs In Oncology Research
Dr. Anthony Everhart (Clinical VP, Internal Medicine, Signant Health) and Tim Meyer (Professor, Experimental Cancer Medicine, University College London) discuss opportunities for increasing the usefulness of PROMs.
7 eCOA Design Recommendations: Insights From Sites And CRAs
Signant joined a group of C-Path members including other eCOA solution providers, sponsors, and regulators for a GBTI project that revealed several opportunities to improve eCOA usability and flexibility.
Still Using Paper Diaries To Capture PRO Data? Read This.
Access real-world examples of how electronic patient-reported outcome measures (PROMs) optimize data quality and reliability and improve the statistical power of trial data.
Optimal COA Measurement Strategy In Modern Oncology Trials
Consider these factors when contemplating an ideal Clinical Outcome Assessment measurement strategy while incorporating patient-reported outcome measures in oncology investigations.
EMA Paper Overview: Decentralized Elements In Clinical Trials
Review a summary of themes highlighted from the recent EMA recommendation paper concerning decentralized components within regulatory submissions for clinical trials.
What 4 Things Do All eCOA Studies Need To Succeed?
Learn what else, in addition to good technology, study teams need for eCOA studies to succeed.
3 Themes And Takeaways From FDA’s Draft Guidance On DCTs
Get our experts’ summary of recent regulatory guidance as well as recommendations for optimal decentralized clinical trial design and conduct.
Unified Platform Supports Rapid Implementation Of Rescue Study
Explore how these integrated solutions helped an emerging biopharma to implement a plan for study build and migration with minimal disruption to sites.
eSource For A COVID Treatment Trial
Unearth how this emerging biopharmaceutical company was able to overcome challenges to successfully facilitate a Phase 2 trial for a COVID-19 treatment in critically ill patients.
Emerging Biopharm Rapidly Sets Up Phase 1 Oncology Trial
Uncover how an emerging biopharmaceutical company was able to expedite the initiation of a Phase 1 oncology trial for a novel treatment targeting relapsed/refractory multiple myeloma.
eClinical Platform Accelerates COVID-19 Treatment Trial By 2 Weeks
Examine a COVID-19 treatment trial that utilized integrated EDC, eConsent, eCOA, RTSM, and TeleVisit solutions, all within a single platform, to address three critical challenges.
Best Practices For Changing From One eClinical Vendor To Another
Switching solution providers mid-study isn't uncommon. But how can teams avoid schedule delays, interrupted operations, and errors? Learn best practices from this example by Signant Biotech.
Breakthrough Therapy Designation Accelerates Oncology Treatment Development
Find out how this evidence-generation company's solutions and scientific expertise enabled early and successful regulatory submission for a novel oncology therapeutic.
Global Pharmaceutical Company Implements Remote Clinician Ratings
Uncover the secret to how this pharma company was able to implement remote clinician ratings in a multinational Alzheimer’s disease.